Arcensus: Arndt Rolfs, Michael Schlenk
Jan 12, 2022
Arndt Rolfs has been appointed as CEO of German direct-to-consumer diagnostic genomic testing company Arcensus. He is succeeding Michael Schlenk, who will remain on the company's supervisory board. Rolfs, who founded Arcensus in December 2020, is the former CEO of Centogene, a post he left abruptly in October 2020. He is also a professor of neuro-regeneration at the University of Rostock in Germany.